Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia

Clinical trial NCT06832371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06832371
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Homozygous Familial Hypercholesterolemia (HoFH)Major Adverse Cardiovascular Events (MACE)Dyslipidemia

Start date: 2024-09-09
Primary completion: 2026-12-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.